Navigation Links
Webmedx and NLP International Team to Bring Natural Language Processing Software to Medical Transcription
Date:9/27/2010

ORLANDO, Fla., Sept. 28 /PRNewswire/ -- Webmedx, the third largest medical transcription service provider in the U.S. and a premier supplier of speech recognition and quality analytics technology, today announced a partnership agreement with NLP International Corporation (NLPI), that will extend Webmedx’s technology and service solutions. Specifically, the partnership will enhance the data mining and search capabilities of the company’s QualityAnalytics™ product line. The announcement was made by Sean Carroll, CEO, Webmedx, at the 82nd AHIMA Convention and Exhibit in Orlando, Florida, Webmedx Booth #2125.

Webmedx will fully integrate NLPI’s advanced natural language processing (NLP) software into their QualityAnalytics solution thereby expanding customers’ ability to mine discrete, structured data from physicians’ transcribed, narrative reports. Termed Narradata™, this information can be used for a wide variety of secondary data uses in healthcare including core measures reporting, meaningful use quality reporting and clinical documentation improvement for RAC and other recovery audits.

“In today’s healthcare environment there are huge pressures to keep costs down while reporting and information requirements continue to rise. Increased productivity from technology, such as NLP, is needed to achieve these competing goals,” mentions Carroll. With QualityAnalytics, users search for specific data elements across literally thousands of narrative, transcribed reports in a matter of milliseconds resulting in a 60% time savings for nurses and other quality reviewers.  The technology also supports the coding process and accelerates the populating of electronic health records (EHRs).

The company chose NLPI because of their ability to support the high volume / high demand data requirements of healthcare. Their NLP search engine was developed over 20 years at Columbia University and is currently utilized at Columbia University Medical Center, one of the largest academic medical centers in the U.S.  

Bernie Keppler, CEO, NLPI, explains that the partnership with Webmedx provides a perfect opportunity to leverage the power of NLP data mining and the company is honored to have been selected as their search technology partner. “The role, size and industry reputation of Webmedx, coupled with their technical expertise make this an ideal fit for our companies and our customers,” he concludes.

About WebmedxWebmedx, Inc. is the 3rd largest supplier of medical transcription services and clinical documentation technology for hospitals and clinics nationally. Recently named one of Healthcare Informatics’ Top 100 Companies and 2009 Best in KLAS for Outsourced Transcription according to the 2009 Top 20 Best in KLAS Awards: Software & Professional Services report, December 2009, the company designs and implements customer-centric documentation solutions using the most credentialed domestic workforce in the industry and its own enterprise-class, intelligent speech recognition and clinical data mining technology platforms.  For more information, go to www.webmedx.com, email sales@webmedx.com, or call 877-846-1200.

About NLP International CorporationNLP International Corporation offers healthcare professionals a patented world-class Natural Language Processing Solution: MedLee™. MedLee has been successfully commercialized from Columbia University over the past 18 months and is now the market leader in Natural Language Processing technology. With its unique deployment model, NLP International makes this world-class solution available through the MedLee Portal. The MedLee Portal is a SaaS offering that has applications ranging from Quality to Semantic Search and Retrieval to Computer Assisted Coding and Meaningful use.  For more information, go to www.nlpapplications.com, or call 203-286-6564.For more information call:Beth Friedman, PresidentThe Friedman Marketing Group770.335.8570beth@tfmgcom.com
'/>"/>

SOURCE Webmedx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Webmedx Strengthens Quality Program and Improves Patient Safety in Compliance with New Industry Standards for Clinical Documentation
2. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
3. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
4. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
5. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
6. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
7. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
8. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
9. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... Oasmia Pharmaceutical AB (NASDAQ: ... new generation of drugs within human and veterinary ... Paclical/Apealea in the Phase III study that included ... cancer. These preliminary results showed non-inferiority between the ... versus Taxol in combination with carboplatin. In fact, ...
(Date:4/27/2016)... At the Sachs CEO forum ... Phase 2 clinical study of its lead drug candidate, ... implantation (CI) surgery. This large, placebo-controlled, double-blind, phase 2 ... and France . STR001 ... time of surgery. "Despite advances in cochlear implant technology, ...
(Date:4/26/2016)... April 26, 2016 US demand for ... expand 4.9 percent annually to $27.6 billion in ... facilities to decrease rates of healthcare-associated infections (HAIs) ... equipment, and services.  Although declining, the overall rate ... targeted levels set by the CDC.  Recent statistics ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 30, 2016 , ... World Patent Marketing ... Up Springboard, an automotive invention that improves the storage features of a pick ... billion," says Scott Cooper, CEO and Creative Director of World Patent Marketing. "Over ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... , announces the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula ... brain and mood optimization products to the store is just one more way ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House announced ... loans, more information about their loan terms and accounts, and more protections for ... including federal and private loans, has reached $1.3 trillion, with 43 million Americans ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Wharton ... $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan Competition —as ... People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ making them ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the ... smiles. Cosmetic dentistry is a fast-growing field as more patients are discovering the many ... learn more about the options currently available to them and which ones might work ...
Breaking Medicine News(10 mins):